These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29020401)

  • 1. Discrimination of patients with type 2 myocardial infarction.
    Neumann JT; Sörensen NA; Rübsamen N; Ojeda F; Renné T; Qaderi V; Teltrop E; Kramer S; Quantius L; Zeller T; Karakas M; Blankenberg S; Westermann D
    Eur Heart J; 2017 Dec; 38(47):3514-3520. PubMed ID: 29020401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
    Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction.
    Nestelberger T; Boeddinghaus J; Lopez-Ayala P; Kaier TE; Marber M; Gysin V; Koechlin L; Sanchez AY; Giménez MR; Wussler D; Walter JE; Strebel I; Zimmermann T; Glarner N; Miró Ò; Martin-Sanchez FJ; Zehnder T; Twerenbold R; Keller DI; Mueller C;
    JAMA Cardiol; 2021 Jul; 6(7):771-780. PubMed ID: 33881449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of high-sensitivity cardiac troponin T and I in the early differentiation of type 1 vs. type 2 myocardial infarction.
    Nestelberger T; Boeddinghaus J; Giménez MR; Lopez-Ayala P; Ratmann PD; Badertscher P; Wildi K; Wussler D; Koechlin L; Arslani K; Zimmermann T; Freese M; Rinderknecht T; Miró Ò; Martin-Sanchez FJ; Kawecki D; Geigy N; Keller D; Twerenbold R; Müller C;
    Eur Heart J Acute Cardiovasc Care; 2022 Jan; 11(1):62-74. PubMed ID: 34195803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
    Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
    Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
    Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Kassem M; Ayala PL; Andric-Cancarevic T; Tajsic M; Vargas KG; Bendik D; Kaufmann C; Wojta J; Mueller C; Huber K
    Int J Cardiol; 2024 May; 403():131879. PubMed ID: 38369132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
    Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
    BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.
    Rocheleau S; Eng-Frost J; Lambrakis K; Khan E; Chiang B; Wattchow N; Steele S; Lorensini S; Lehman SJ; Papendick C; Chew DP
    Heart Lung Circ; 2023 Aug; 32(8):978-985. PubMed ID: 37225600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
    White K; Kinarivala M; Scott I
    BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
    Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-targeted metabolic profile differences between emergency patients with type 1 and type 2 myocardial infarction diagnosed by optical coherence tomography.
    Wang J; Li Z; Yang G; Fang C; Yin Y; Zheng Z; Wang H; Fang S; Dai J; Wang S; Yang S; Yu B
    Clin Chim Acta; 2024 Feb; 554():117745. PubMed ID: 38185283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Biomarker Model to Distinguish Types of Myocardial Infarction and Injury.
    Neumann JT; Weimann J; Sörensen NA; Hartikainen TS; Haller PM; Lehmacher J; Brocks C; Tenhaeff S; Karakas M; Renné T; Blankenberg S; Zeller T; Westermann D
    J Am Coll Cardiol; 2021 Aug; 78(8):781-790. PubMed ID: 34412811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute versus chronic myocardial injury and long-term outcomes.
    Kadesjö E; Roos A; Siddiqui A; Desta L; Lundbäck M; Holzmann MJ
    Heart; 2019 Dec; 105(24):1905-1912. PubMed ID: 31337668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
    Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
    Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External Validation and Extension of a Clinical Score for the Discrimination of Type 2 Myocardial Infarction.
    Nestelberger T; Lopez-Ayala P; Boeddinghaus J; Strebel I; Rubini Gimenez M; Huber I; Wildi K; Wussler D; Koechlin L; Prepoudis A; Gualandro DM; Puelacher C; Glarner N; Haaf P; Frey S; Bakula A; Wick R; Miró Ò; Martin-Sanchez FJ; Kawecki D; Keller D; Twerenbold R; Mueller C
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33803801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
    J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.